Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
Date:11/1/2007

/p>

restructuring were the decisions to discontinue further development of

ANA380, a nucleotide analog for the treatment of hepatitis B virus

(HBV) infection, halt all work on early discovery projects, and effect

an immediate reduction in force of approximately one-third of the

Company's employees, with several additional positions to be eliminated

in early 2008.

Recent Scientific Presentations

-- Reported ANA773 Dose Schedule Data. On October 25, 2007, Anadys

presented preclinical data on ANA773 during a poster session at the

2007 AACR-NCI-EORTC International Conference on Molecular Targets and

Cancer Therapeutics. The report showed the impact that varying the

dosing schedule has on the pharmacodynamic response to ANA773, a

prodrug of a toll-like receptor 7 agonist. Specifically, the report

described that immunostimulatory responses to ANA773 in vivo can be

modulated by schedule of administration.

-- Reported ANA598 Preclinical Data. On September 11, 2007, Anadys

presented preclinical data on ANA598, a non-nucleoside inhibitor of the

HCV NS5B polymerase, during a poster session at the 14th International

Symposium on Hepatitis C Virus and Related Viruses. The report

characterized the favorable antiviral, metabolic, pharmacokinetic and

preliminary toxicologic properties that supported the decision

announced in June to progress ANA598 to IND enabling studies and

subsequent clinical evaluation expected to commence in the second

quarter of 2008.

Webcast of Conference Call

Anadys will host a conference call today at 5:00 p.m. Eastern Daylight Time to discuss its third quarter financial results and operational highlights and to give an update on its programs. A live webcast of the call will be available online at '/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... shelled out for crude 3-D glasses, polarized glasses, ... These basic devices, used to trick the brain ... be rendered obsolete with the introduction of new ... , TAU doctoral students Yuval Yifat, Michal Eitan, ... based on nanoantennas that could be used for ...
(Date:7/10/2014)... see the two universities and NPL collaborate to bring ... industry and their complementary academic strengths., Working with BIS ... the scientific priorities of the UK. The establishment of ... high-calibre PhD students, will provide a pipeline of skilled ... of the Laboratory will be grown through the creation ...
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 The Pittcon Organizing ... of Food Safety Tech , an e-Journal and producer ... an agreement for the second year for the co-location of ... 2014. The partnership provides that the registration fee to attend ...
Breaking Biology Technology:Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 2Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 3A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3
... CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE , Signature ... science books , SEATTLE, Nov. 17 Despite Darwinists, attempts ... controversial theory of intelligent design made Amazon.com,s list of the year,s ... 150 years since Charles Darwin published his own theory in his ...
... Hungary, Nov. 17 Hungarian drug producer Biropharma and ... connection American BioSciences Inc. and its partner Mate Hidvegi ... Avemar, a dietary supplement being used in cancer treatment ... two different sets of compounds hence the qualities of ...
... ... (DOE) Argonne National Laboratory has been awarded the HPCwire,s Readers, Choice Award for Best ... HPCwire, at the annual Supercomputing Conference (SC09), currently ongoing in Portland, Ore. , ... Portland, OR (Vocus) Nov. ...
Cached Biology Technology:Intelligent Design Book Delivers Blow to Darwin 2Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra 2Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 2Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 3Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 4
(Date:7/10/2014)... , July 2, 2014 It is a ... announce the appointment of the world-renowned Thoracic and Cardiovascular ... Directors. Dr. Ginsburg, with over 34 years ... Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. ... the late 1980,s and is considered an expert in ...
(Date:7/10/2014)... DUBLIN , July 3, 2014 ... the addition of the "Global Gesture Recognition ... Market - Forecasts to 2020" report to ... Global Gesture Recognition & Touch-Less Sensing ... been around for a while, but the companies ...
(Date:7/10/2014)... , July 8, 2014 ... a new design win (DW). An Asian OEM has selected ... mass production start in August 2014.   FPC ... OEM, which has a planned date for start of mass ... ramp order of SEK 5M, for delivery in the first ...
Breaking Biology News(10 mins):Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
... LEXINGTON, Ky. (July 13, 2009) Researchers at ... Center for Toxicology (GCT) have gained new insight into ... or neuromuscular disorders caused by trinucleotide repeats (or TNRs) ... laboratory of Dr. Guo-Min Li, UK professor of toxicology ...
... no surprise that some babies are more difficult to soothe ... that this is not necessarily an indication of their parenting ... , a journal of the Association for Psychological Science, children,s ... a certain gene and a specific pattern of brain activity. ...
... one of the best known and extensively studied organisms in ... to human diseases, such as cancer. The team, funded ... at the University of Dundee has examined the genome sequence of ... that, it turns out, are essential for the survival of ...
Cached Biology News:Researchers gain insight into mechanism underlying Huntington's 2Hush little baby... Linking genes, brain and behavior in children 2Mystery E. coli genes essential for survival of many species 2
...
...
...
... Easy Clean spin filters allow for the ... Simply place your DNA gel slice in the ... majority of your DNA is recovered. There is ... special buffers. Spin filters can also be ...
Biology Products: